Investors Careers FAQ Contact COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS Regenerating Health Transforming the lives of patients with insulin-requiring diabetes COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS CONTACT Copyright 2021 ViaCyte, Inc. All Rights Reserved Terms of Service Privacy Policy We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT

Investors Careers FAQ Contact COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS Investors ViaCyte is a privately-funded regenerative medicine company focused on cell replacement therapies for unmet medical needs. Our investors are major supporters and experienced partners in the life science sectors. Working with them, we believe we can realize the promise of ViaCyte’s break-through technologies for the benefit of patients and investors alike. COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS CONTACT Copyright 2021 ViaCyte, Inc. All Rights Reserved Terms of Service Privacy Policy We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT

Investors Careers FAQ Contact COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS Partnerships and Licensing Agreements ViaCyte has a number of key partnerships with world-class companies, providing us with important expertise and technologies to help us reach our important goals. In addition, our expanding know-how and intellectual property portfolio has the potential to provide cell therapies that expand well beyond the Company’s current focus in diabetes. As well, the expertise we are developing for effective delivery of cells, including the Encaptra® system, could be used in the development of a wide range of medical products. ViaCyte welcomes the exploration of research and business opportunities. Please contact us for further information. COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS CONTACT Copyright 2021 ViaCyte, Inc. All Rights Reserved Terms of Service Privacy Policy We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT